Sponsors (3)
The bill strengthens animal welfare, food safety, worker protections, and regulatory transparency, but does so with significant compliance, administrative, and legal costs that could raise prices and strain small producers and government capacity.
Consumers and public-health systems: pork safety improves because nonambulatory (sick/injured) pigs are barred from processing and testing/reporting for pathogens will reduce foodborne illness and outbreak risk.
Workers and potential whistleblowers: clearer definitions of who is covered plus a confidential reporting channel and judicial review make it easier to report abuse and seek remedies without fear, strengthening legal protections for employees at covered facilities.
Farm, transport and slaughter workers: mandated handling standards, mechanical lifting aids, training, and improved transport conditions reduce workplace injuries, stress, and inhumane handling.
Small producers, processors, and consumers: the bill creates substantial new compliance costs (facility/equipment upgrades, testing, recordkeeping, staffing) and may reduce production efficiency, which can raise prices and squeeze small operators.
Employers and workers: broader definitions of covered individuals, limits on arbitration, and expanded complaint processes increase litigation and administrative costs for businesses and may still leave gaps that expose whistleblowers to risk in some circumstances.
Federal and local agencies and small/rural operations: new reporting, testing, and enforcement duties increase administrative burden and require funding and capacity that may strain USDA/FSIS and be difficult for small or remote facilities to meet.
Based on analysis of 8 sections of legislative text.
Bans most beta‑agonist feed drugs in pigs, requires humane handling/euthanasia and testing for nonambulatory pigs, mandates USDA/OSHA rules, a complaint portal, and whistleblower protections.
Introduced July 25, 2025 by Veronica Escobar · Last progress July 25, 2025
Prohibits use of certain growth‑promoting beta‑adrenergic drugs in pigs (except for treating disease) and requires humane handling, prompt euthanasia, disease testing, recordkeeping, and other controls for nonambulatory pigs across the production, transport, and slaughter chain. It directs USDA and OSHA to issue regulations and standards, creates a confidential online complaint portal with whistleblower protections, and requires a public study on pathogens associated with nonambulatory pigs.